New 21-valent and 20-valent pneumococcal vaccines to be administered concurrently in Taiwan; one dose is sufficient, no choice allowed

Taiwan's public health system is rolling out a new 21-valent pneumococcal vaccine, which will be administered alongside the existing 20-valent version. Health authorities in Changhua County are urging eligible residents to get vaccinated, emphasizing that recipients cannot choose which vaccine they receive, similar to the annual flu shot.

Both the 21-valent and 20-valent vaccines require a single dose and offer the same level of protection against pneumococcal diseases, including pneumonia, sepsis, and meningitis. The health bureau advises that vaccination is crucial before the peak season for respiratory illnesses in autumn and winter, as it takes at least two weeks for antibodies to develop.

“

Come what may, you get what you get, and you can't choose.

The public vaccination program is available to individuals aged 65 and older, Indigenous people aged 55 to 64, and high-risk groups aged 19 to 64. These high-risk groups include those with spleen dysfunction, compromised immune systems, cochlear implants, cerebrospinal fluid leaks, or those undergoing cancer treatment within the past year. Organ transplant recipients are exempt from the one-year restriction.

Authorities remind the public that individuals who have already received one dose of PCV13 (or PCV15) and PPV23, or a single dose of PCV20 or the new PCV21, have completed their public pneumococcal vaccination and do not need further doses. In addition to vaccination, the health bureau stresses the importance of preventive measures such as frequent handwashing, proper cough etiquette, maintaining good indoor ventilation, and avoiding crowded, poorly ventilated areas.

“

Get vaccinated as soon as possible before the virus season to get protection.